State Street’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,626,859
| Closed | -$29.5M | – | 4379 |
|
|
2025
Q2 | $29.5M | Sell |
2,626,859
-464,330
| -15% | -$2.65M | ﹤0.01% | 1969 |
|
|
2025
Q1 | $14.1M | Sell |
3,091,189
-144,558
| -4% | -$968K | ﹤0.01% | 2317 |
|
|
2024
Q4 | $18.2M | Sell |
3,235,747
-1,017,470
| -24% | -$5.74M | ﹤0.01% | 2276 |
|
|
2024
Q3 | $20.6M | Buy |
4,253,217
+903,809
| +27% | +$5.25M | ﹤0.01% | 2187 |
|
|
2024
Q2 | $16.3M | Sell |
3,349,408
-1,748,000
| -34% | -$11M | ﹤0.01% | 2272 |
|
|
2024
Q1 | $67.7M | Buy |
5,097,408
+1,230,644
| +32% | +$16.3M | ﹤0.01% | 1550 |
|
|
2023
Q4 | $53.9M | Buy |
3,866,764
+589,584
| +18% | +$7.31M | ﹤0.01% | 1664 |
|
|
2023
Q3 | $43.5M | Buy |
3,277,180
+214,148
| +7% | +$3.45M | ﹤0.01% | 1704 |
|
|
2023
Q2 | $57.4M | Sell |
3,063,032
-286,745
| -9% | -$4.78M | ﹤0.01% | 1581 |
|
|
2023
Q1 | $48.3M | Sell |
3,349,777
-1,121,272
| -25% | -$22M | ﹤0.01% | 1673 |
|
|
2022
Q4 | $86.5M | Buy |
4,471,049
+1,671,215
| +60% | +$44.3M | 0.01% | 1258 |
|
|
2022
Q3 | $96.2M | Buy |
2,799,834
+2,194,551
| +363% | +$70M | 0.01% | 1125 |
|
|
2022
Q2 | $9.25M | Sell |
605,283
-2,057,823
| -77% | -$31.9M | ﹤0.01% | 2776 |
|
|
2022
Q1 | $60.8M | Buy |
2,663,106
+899,742
| +51% | +$25.7M | ﹤0.01% | 1636 |
|
|
2021
Q4 | $65M | Buy |
1,763,364
+1,524,355
| +638% | +$64M | ﹤0.01% | 1630 |
|
|
2021
Q3 | $11.2M | Buy |
+239,009
| New | +$14.1M | ﹤0.01% | 2821 |
|
Other funds holding VERV
GCM
BIG
IA
